Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
6.71M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
134K
-
Shares change
-
+12.2K
-
Total reported value, excl. options
-
$647K
-
Value change
-
-$323K
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$4.83
Significant Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) as of Q1 2024
15 filings reported holding VVOS - Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share as of Q1 2024.
Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 134K shares
of 6.71M outstanding shares and own 2% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (104K shares), COMMONWEALTH EQUITY SERVICES, LLC (15K shares), VANGUARD GROUP INC (10.6K shares), Newbridge Financial Services Group, Inc. (1.95K shares), Tower Research Capital LLC (TRC) (1.73K shares), SIGNATUREFD, LLC (547 shares), GROUP ONE TRADING, L.P. (228 shares), Blue Trust, Inc. (160 shares), BANK OF AMERICA CORP /DE/ (80 shares), and MORGAN STANLEY (67 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.